Low-dose aspirin use and survival in colorectal cancer: results from a population-based cohort study

BMC Cancer
Ronan T GrayChris R Cardwell

Abstract

Aspirin has been proposed as a novel adjuvant agent in colorectal cancer (CRC). Six observational studies have reported CRC-specific survival outcomes in patients using aspirin after CRC diagnosis but the results from these studies have been conflicting. Using a population-based cohort design this study aimed to assess if low-dose aspirin use after diagnosis reduced CRC-specific mortality. A cohort of 8391 patients with Dukes' A-C CRC (2009-2012) was identified from the Scottish Cancer Registry and linked to national prescribing and death records. Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for CRC-specific mortality were calculated using time-dependent Cox regression. There were 1064 CRC-specific deaths after a median follow-up of 3.6 years. Post-diagnostic low-dose aspirin use was not associated with a reduction in CRC-specific mortality either before or after adjustment for confounders (adjusted HR = 1.17, 95% CI 1.00-1.36). In sensitivity analysis pre-diagnostic low-dose aspirin was also not associated with reduced CRC-specific mortality (adjusted HR = 0.96, 95% CI 0.88-1.05). Low-dose aspirin use, either before or after diagnosis, did not prolong survival in this population-based CRC cohort.

References

Jan 1, 1993·American Journal of Epidemiology·C R Weinberg
Dec 25, 2004·Journal of Clinical Epidemiology·Vijaya SundararajanWilliam A Ghali
Jan 25, 2007·Pharmacoepidemiology and Drug Safety·H TamimJ LeLorier
Apr 17, 2008·Pharmacoepidemiology and Drug Safety·Yu-Xiao YangJames D Lewis
Feb 13, 2009·Journal of the National Cancer Institute·Bernard F ColeJohn A Baron
Jun 16, 2009·Epidemiology·Enrique F SchistermanRobert W Platt
Aug 13, 2009·JAMA : the Journal of the American Medical Association·Andrew T ChanCharles S Fuchs
Mar 17, 2010·BMJ : British Medical Journal·Linda E LévesqueSamy Suissa
May 12, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Peter D BaadeSuzanne K Chambers
Oct 12, 2012·Cancer Causes & Control : CCC·Josephina G KuiperPolly A Newcomb
Oct 26, 2012·The New England Journal of Medicine·Xiaoyun LiaoShuji Ogino
Nov 28, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C McCowanR J C Steele
Aug 14, 2013·Journal of the National Cancer Institute·Jessica ChubakNoel S Weiss
Aug 6, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chris R CardwellLiam J Murray
Aug 12, 2014·BMC Evolutionary Biology·Alex DornburgThomas J Near
May 12, 2016·International Journal of Epidemiology·Samantha Alvarez-MadrazoMarion Bennie
Jun 2, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Simer J BainsKjetil Taskén
Jan 20, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Amelia SmithThomas I Barron

❮ Previous
Next ❯

Citations

Nov 24, 2019·British Journal of Clinical Pharmacology·Marion BennieTanja Mueller
Mar 13, 2020·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Natalia L KomarovaDominik Wodarz
Aug 12, 2018·International Journal of Molecular Sciences·Altaf MohammedChinthalapally V Rao
Nov 30, 2019·Journal of Public Health·Xianmin WangKui Zhang
Jan 12, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Yaschilal Muche BelaynehBirhanu Geta Meharie
Feb 3, 2021·Journal of the National Cancer Institute·Jane C FigueiredoPeter T Campbell

❮ Previous
Next ❯

Clinical Trials Mentioned

ISRCTN74358648
NCT02467582
NCT02301286
NCT00565708

Software Mentioned

STATA

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Reema A KarasnehChris R Cardwell
© 2022 Meta ULC. All rights reserved